Oncology Imperatives: Adaptive Trial Design

Understanding the benefits of innovative clinical trial designs in oncology drug development

Listen as Dr. Albert Tsai, regional medical officer in Asia-Pacific for PPD Biotech, hosts a discussion with our adaptive trial design experts, Dr. Dirk Reitsma, senior vice president of oncology medical and scientific strategy, and Jürgen Hummel, senior director of statistical science. They clear up common misconceptions and build a strong case for the use of adaptive designs.

Learn more about our proven oncology and hematology experience.